Case number 2020-1273
Par Pharmaceutical, Inc. v. Hospira, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 4, 2021 | 0 | PAR PHARMACEUTICAL, INC. v. HOSPIRA, INC. [OPINION] [nonprecedential] (0) |
| Dec 30, 2020 | 46 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [745938] [JAB] [Entered: 12/30/2020 08:38 AM] (1) |
| Nov 23, 2020 | 45 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Each Side Bears Its Own Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [737521] [MJL] [Entered: 11/23/2020 09:32 AM] (1) |
| Nov 23, 2020 | 44 | OPINION filed for the court by Dyk, Circuit Judge; Taranto, Circuit Judge and Stoll, Circuit Judge. Nonprecedential Opinion. [737519] [MJL] [Entered: 11/23/2020 09:31 AM] (16) |
| Nov 5, 2020 | 43 | Submitted after ORAL ARGUMENT to Panel: Dyk, Circuit Judge; Taranto, Circuit Judge and Stoll, Circuit Judge.Arguing counsel: Thomas J. Meloro for Hospira, Inc. and Daniel Brown for Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC.Oral Argument Audio available here. [733911] [JAB] [Entered: 11/05/2020 12:46 PM] (0) |
| Oct 19, 2020 | 42 | Clerk's letter to Appellant Hospira, Inc. and Appellees Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [729731] [JAB] [Entered: 10/19/2020 11:07 AM] (0) |
| Oct 15, 2020 | 41 | Response to notice of oral argument from the Appellees Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. Service: 10/15/2020 by email. [729153] [20-1273] [Daniel Brown] [Entered: 10/15/2020 04:03 PM] (1) |
| Oct 15, 2020 | 40 | Response to notice of oral argument from the Appellant Hospira, Inc.. Service: 10/15/2020 by email. [729120] [20-1273] [Thomas Meloro] [Entered: 10/15/2020 03:14 PM] (1) |
| Sep 21, 2020 | 39 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2011K. Case scheduled November 5, 2020. Response to Notice of Oral Argument due: 10/15/2020. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [723196] [JAB] [Entered: 09/21/2020 01:27 PM] (1) |
| Aug 13, 2020 | 38 | 6 paper copies of the Corrected Confidential Joint Appendix (Vol. I-VI) [34] received from Hospira, Inc. [717289] [MJL] [Entered: 08/25/2020 10:49 AM] (0) |
| Aug 6, 2020 | 36 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The corrected nonconfidential appendix [35] was not text-searchable. CORRECTION: Pursuant to the court's Electronic Filing Procedures, filings must be text-searchable in their entirety. Please ensure future filings adhere to this requirement. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [713059] [MJL] [Entered: 08/06/2020 01:58 PM] (0) |
| Aug 5, 2020 | 37 | 6 paper copies of the Opening Response Brief [16] received from Appellees Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. [714115] [CJF] [Entered: 08/11/2020 11:50 AM] (0) |
| Aug 5, 2020 | 35 | MODIFIED ENTRY: CORRECTED APPENDIX FILED for Hospira, Inc. Number of Pages: 2407. Service: 08/05/2020 by email. [712793]--[Edited 08/06/2020 by MJL - compliance review complete] [Matthew Freimuth] [Entered: 08/05/2020 03:52 PM] (2407) |
| Aug 5, 2020 | 34 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL APPENDIX FILED for Hospira, Inc. Number of Pages: 2389. Service: 08/05/2020 by email. Paper copies of this appendix are due no later than 08/13/2020 (see Admin. Order No. 20-01). [712783]--[Edited 08/06/2020 by MJL - compliance review complete] [Matthew Freimuth] [Entered: 08/05/2020 03:41 PM] (0) |
| Aug 5, 2020 | 33 | Notice of Correction to Doc No. [23] for Appellant Hospira, Inc.. Service: 08/05/2020 by email. [712773] [20-1273] [Matthew Freimuth] [Entered: 08/05/2020 03:23 PM] (5) |
| Aug 5, 2020 | 32 | The following conflict dates submitted by Thomas J. Meloro for Hospira, Inc. have been accepted by the court: 12/10/2020, 12/11/2020, 02/05/2021. [712580] [JAB] [Entered: 08/05/2020 07:15 AM] (0) |
| Aug 4, 2020 | 31 | Notice from Appellant Hospira, Inc. regarding conflicts with oral argument. Service: 08/04/2020 by email. [712520] [20-1273] [Thomas Meloro] [Entered: 08/04/2020 05:07 PM] (3) |
| Aug 4, 2020 | 29 | NOTICE OF NON-COMPLIANCE: The submission of Appellees Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC, paper copies of the Opening Response Brief [28], is not in compliance with the rules of this court (see attached). Compliant document due on 08/11/2020. Service as of this date by the Clerk of Court. [712354] [CJF] [Entered: 08/04/2020 12:20 PM] (1) |
| Jul 31, 2020 | 30 | 6 paper copies of the Opening Brief [12] received from Appellant Hospira, Inc. [712370] [CJF] [Entered: 08/04/2020 12:44 PM] (0) |
| Jul 31, 2020 | 28 | 6 paper copies of the Opening Response Brief [16] received from Appellees Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. This document is non-compliant. See Doc No.[29] [712353] [CJF] [Entered: 08/04/2020 12:17 PM] (0) |
| Jul 30, 2020 | 27 | 6 paper copies of the Reply Brief [17] received from Appellant Hospira, Inc. [711629] [CJF] [Entered: 07/31/2020 02:08 PM] (0) |
| Jul 28, 2020 | 26 | Outstanding paper copies of all briefs and appendices must be submitted no later than 08/11/2020. See Admin Order No. 20-01 (March 20, 2020). [710537] [MJL] [Entered: 07/28/2020 10:07 AM] (0) |
| Jul 28, 2020 | 25 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [710530] [MJL] [Entered: 07/28/2020 09:58 AM] (1) |
| Jun 4, 2020 | 24 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL APPENDIX FILED for Hospira, Inc. Number of Pages: 2380. Service: 06/04/2020 by email. [699349]--[Edited 06/24/2020 by LMN - compliance review complete]. This appendix has been corrected. See Doc. No. [34]. [Matthew Freimuth] [Entered: 06/04/2020 05:38 PM] (0) |
| Jun 4, 2020 | 23 | MODIFIED ENTRY: CORRECTED APPENDIX FILED for Hospira, Inc. Number of Pages: 2395. Service: 06/04/2020 by email. [699346] --[Edited 06/24/2020 by LMN - compliance review complete]. This appendix has been corrected. See Doc. No. [35]. [Matthew Freimuth] [Entered: 06/04/2020 05:27 PM] (2395) |
| May 28, 2020 | 22 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Hospira, Inc., Confidential and Non-Confidential Appendices [18], [19], is not in compliance with the rules of this court (see attached). Compliant documents are due on 06/04/2020. Service as of this date by the Clerk of Court. [697511] [LMN] [Entered: 05/28/2020 11:28 AM] (1) |
| May 15, 2020 | 21 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Hospira, Inc.. Service: 05/15/2020 by email. [695119] [20-1273] [Thomas Meloro] [Entered: 05/15/2020 08:10 PM] (3) |
| May 15, 2020 | 20 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Hospira, Inc.. Service: 05/15/2020 by email. [695118] [20-1273] [Thomas Meloro] [Entered: 05/15/2020 08:09 PM] (3) |
| May 15, 2020 | 19 | FILED from Appellant Hospira, Inc. Title: CONFIDENTIAL APPENDIX. Service: 05/15/2020 by email. This document has been corrected. See doc. [24] [695117] [20-1273]. This appendix is non-compliant. See Doc. No. [22].--[Edited 06/24/2020 by LMN] [Thomas Meloro] [Entered: 05/15/2020 08:06 PM] (0) |
| May 15, 2020 | 18 | FILED from Appellant Hospira, Inc. Title: APPENDIX. Service: 05/15/2020 by email. This document has been corrected. See doc. [23] [695116] [20-1273]. This appendix is non-compliant. See. Doc. No. [22]--[Edited 06/24/2020 by LMN] [Thomas Meloro] [Entered: 05/15/2020 07:55 PM] (2385) |
| May 8, 2020 | 17 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellant Hospira, Inc.. Number of Pages: 40. Service: 05/08/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [693277] --[Edited 05/19/2020 by LMN - compliance review complete] [Thomas Meloro] [Entered: 05/08/2020 03:53 PM] (40) |
| Apr 17, 2020 | 16 | MODIFIED ENTRY: BRIEF FILED for Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., and Par Sterile Products, LLC. Number of Pages: 65. Service: 04/17/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [688087]--[Edited 04/27/2020 by MJL - compliance review complete] [Daniel Brown] [Entered: 04/17/2020 08:48 PM] (78) |
| Feb 27, 2020 | 15 | **TEXT ONLY** ORDER granting motion to extend time to file brief [13] filed by Appellees Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC. The response brief is due 04/17/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [674810] [JAL] [Entered: 02/27/2020 01:20 PM] (0) |
| Feb 27, 2020 | 14 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [674808] [JAL] [Entered: 02/27/2020 01:19 PM] (0) |
| Feb 24, 2020 | 13 | MOTION of Appellees Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC to extend the time to 04/17/2020 to file the Principal Brief. [Consent: unopposed]. Service: 02/24/2020 by email. [673797] [20-1273] [Daniel Brown] [Entered: 02/24/2020 06:01 PM] (7) |
| Feb 7, 2020 | 12 | MODIFIED ENTRY: OPENING BRIEF FILED for Appellant Hospira, Inc.. Number of Pages: 64. Service: 02/07/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [669506] --[Edited 02/26/2020 by TAM - compliance review complete] [Thomas Meloro] [Entered: 02/07/2020 04:21 PM] (159) |
| Jan 15, 2020 | 11 | Entry of appearance for Devon W. Edwards as of counsel for Appellant Hospira, Inc.. Service: 01/15/2020 by email. [663385] [20-1273] [Devon Edwards] [Entered: 01/15/2020 02:07 PM] (2) |
| Jan 2, 2020 | 10 | Entry of appearance for Matthew Freimuth as of counsel for Appellant Hospira, Inc.. Service: 01/02/2020 by email. [660268] [20-1273] [Matthew Freimuth] [Entered: 01/02/2020 03:36 PM] (2) |
| Jan 2, 2020 | 9 | Docketing Statement for the Appellant Hospira, Inc.. Service: 01/02/2020 by email. [660263] [20-1273] [Thomas Meloro] [Entered: 01/02/2020 03:31 PM] (4) |
| Jan 2, 2020 | 8 | Certificate of Interest for Appellant Hospira, Inc.. Service: 01/02/2020 by email. [660253] [20-1273] [Thomas Meloro] [Entered: 01/02/2020 03:27 PM] (3) |
| Jan 2, 2020 | 7 | Entry of appearance for Thomas J. Meloro as principal counsel for Appellant Hospira, Inc.. Service: 01/02/2020 by email. [660236] [20-1273] [Thomas Meloro] [Entered: 01/02/2020 03:21 PM] (2) |
| Jan 2, 2020 | 6 | Entry of appearance for Gabriel K. Bell as of counsel for Appellees Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC. Service: 01/02/2020 by email. [660133] [20-1273] [Gabriel Bell] [Entered: 01/02/2020 12:56 PM] (3) |
| Jan 2, 2020 | 5 | Entry of appearance for Jennifer Koh as of counsel for Appellees Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC. Service: 01/02/2020 by email. [660131] [20-1273] [Jennifer Koh] [Entered: 01/02/2020 12:52 PM] (3) |
| Jan 2, 2020 | 4 | Docketing Statement for the Appellees Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC. Service: 01/02/2020 by email. [660126] [20-1273] [Daniel Brown] [Entered: 01/02/2020 12:48 PM] (3) |
| Jan 2, 2020 | 3 | Certificate of Interest for Appellees Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC. Service: 01/02/2020 by email. [660125] [20-1273] [Daniel Brown] [Entered: 01/02/2020 12:46 PM] (3) |
| Jan 2, 2020 | 2 | Entry of appearance for Daniel G. Brown as principal counsel for Appellees Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC. Service: 01/02/2020 by email. [660123] [20-1273] [Daniel Brown] [Entered: 01/02/2020 12:44 PM] (3) |
| Dec 19, 2019 | 1 | Appeal docketed. Received: 12/10/2019. [657811]Entry of Appearance due 01/02/2020. Certificate of Interest is due on 01/02/2020. Docketing Statement due 01/02/2020. Appellant's brief is due 02/18/2020. [TAM] [Entered: 12/19/2019 12:58 PM] (31) |
